4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-16-012641
Options or other derivatives
- CFO and EVP acquired 78,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shaff Eric D. · CFO and EVP
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-02-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +78,500 | $26.20 | 2026-01-31 | 78,500 | 78,500 | D |
Loading xslF345X03/doc4.xml…